NKTX – nkarta, inc. (US:NASDAQ)
Stock Stats
News
Nkarta rises on FDA agreement for amended trial protocol [Seeking Alpha]
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers [Yahoo! Finance]
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
Nkarta to Participate in Needham Virtual Healthcare Conference
Nkarta (NKTX) had its price target lowered by Mizuho from $14.00 to $12.00. They now have an "outperform" rating on the stock.
Form EFFECT Nkarta, Inc.
Form 424B5 Nkarta, Inc.
Form 8-K Nkarta, Inc. For: Mar 25
Form S-3 Nkarta, Inc.
Form 10-K Nkarta, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.